Charles River Laboratories International, Inc. (CRL) Institutional Ownership

Ownership Summary

Charles River Laboratories International, Inc. (NYSE:CRL) appears in 566 institutional 13F filings for the quarter ending December 2025.

• These investors held 106.6% of outstanding shares in December 2025, up from 105.3% in September 2025.
• Their total shares held in CRL increased 5.15% quarter over quarter, and separately, investors owning Charles River Laboratories International decreased 10.02% from a year ago.
• Activity in CRL broke down as 286 buyers, 203 sellers, and 77 unchanged among 566 total holders.
• Combined, these investors held 52.69Mn shares in CRL for December 2025, up by 2.58Mn shares quarter on quarter, and down 5.82Mn shares year over year.
• As of December 31, 2025, the biggest holder of Charles River Laboratories International is BlackRock, Inc. at 3.86Mn shares, representing 7.81% of shares outstanding.
• The biggest buyers of Charles River Laboratories International for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (3.2Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.29Mn), FMR LLC (1.72Mn), PRICE T ROWE ASSOCIATES INC /MD/ (1.13Mn), CITADEL ADVISORS LLC (794.64K).
• Top sellers of CRL stock for the quarter ending December 2025 included Woodline Partners LP (342.95K), Invesco Ltd. (298.9K), Ameriprise Financial Inc (275.0K), Walleye Capital LLC (249.19K), D. E. Shaw & Co., Inc. (237.64K).
• Per Business Quant, the top 10 investors in CRL for the quarter ending December 2025 include BlackRock, Inc. (3.86Mn), FMR LLC (3.46Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.2Mn), Invesco Ltd. (2.4Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.29Mn), HARRIS ASSOCIATES L P (2.15Mn), Allspring Global Investments Holdings, LLC (1.99Mn), State Street Corp (1.87Mn), DIMENSIONAL FUND ADVISORS LP (1.65Mn), WELLINGTON MANAGEMENT GROUP LLP (1.63Mn).